Patents by Inventor Jill Melissa Scott

Jill Melissa Scott has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS
    Publication number: 20110021573
    Abstract: Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions and medicaments that include the antagonists of PGD2 receptors described herein, as well as methods of using such antagonists of PGD2 receptors, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other PGD2-dependent or PGD2-mediated conditions or diseases.
    Type: Application
    Filed: February 25, 2009
    Publication date: January 27, 2011
    Applicant: AMIRA PHARMACEUTICALS, INC.
    Inventors: John Howard Hutchinson, Brian Andrew Stearns, Thomas Jonathan Seiders, Jill Melissa Scott, Jeannie M. Arruda, Bowei Wang
  • CYCLOALKANE[B]AZAINDOLE ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS
    Publication number: 20100113503
    Abstract: Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions that include the compounds described herein, and methods of using such antagonists of PGD2 receptors, alone or in combination with other compounds, for treating respiratory, cardiovascular, and other PGD2-dependent or PGD2-mediated conditions or diseases.
    Type: Application
    Filed: November 5, 2009
    Publication date: May 6, 2010
    Applicant: AMIRA PHARMACEUTICALS, INC.
    Inventors: John Howard Hutchinson, Brian Andrew Stearns, Jill Melissa Scott
  • HETEROARYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS
    Publication number: 20100081673
    Abstract: Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions that include the compounds described herein, and methods of using such antagonists of PGD2 receptors, alone or in combination with other compounds, for treating respiratory, cardiovascular, and other PGD2-dependent or PGD2-mediated conditions or diseases.
    Type: Application
    Filed: September 28, 2009
    Publication date: April 1, 2010
    Applicant: AMIRA PHARMACEUTICALS, INC.
    Inventors: John Howard HUTCHINSON, Nicholas Simon STOCK, Jeffrey Roger ROPPE, Jill Melissa SCOTT, Brian Andrew STEARNS, Yen Pham TRUONG, Deborah VOLKOTS, Timothy PARR
  • N,N-DISUBSTITUTED AMINOALKYLBIPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS
    Publication number: 20090197959
    Abstract: Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions that include the compounds described herein, and methods of using such antagonists of PGD2 receptors, alone or in combination with other compounds, for treating respiratory, cardiovascular, and other PGD2-dependent or PGD2-mediated conditions or diseases.
    Type: Application
    Filed: January 29, 2009
    Publication date: August 6, 2009
    Applicant: AMIRA PHARMACEUTICALS, INC.
    Inventors: John Howard HUTCHINSON, Brian Andrew STEARNS, Jill Melissa SCOTT, Yen Pham TRUONG, Jeffrey Roger ROPPE, Nicholas Simon STOCK, Jeannie M. ARRUDA, Thomas Jon SEIDERS, Bowei WANG
  • TRICYCLIC INHIBITORS OF 5-LIPOXYGENASE
    Publication number: 20070173508
    Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which inhibit the activity of 5-lipoxygenase (5-LO). Also described herein are methods of using such 5-LO inhibitors, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions, diseases, or disorders.
    Type: Application
    Filed: January 23, 2007
    Publication date: July 26, 2007
    Applicant: AMIRA PHARMACEUTICALS, INC.
    Inventors: John Howard Hutchinson, Thomas Jonathan Seiders, Brian Andrew Stearns, Bowei Wang, Jill Melissa Scott, Yen Pham Truong
  • Polymorphic and amorphous forms of 2-{3-[(E)-2-(4,6-dimethyl-pyridin-2-yl)-vinyl]-1H-indazol-6-ylamino}-N-(4-hydroxy-but-2-ynyl)benzamide
    Publication number: 20060160863
    Abstract: This invention provides several crystalline polymorphic forms, amorphous forms, and mixtures thereof of the compound of Formula I: and pharmaceutical compositions made therewith, and to the therapeutic or prophylactic use of such compounds and pharmaceutical compositions, to treat ophthalmic diseases, such as age related macular degeneration and other diseases associated with unwanted ocular angiogenesis.
    Type: Application
    Filed: December 14, 2005
    Publication date: July 20, 2006
    Inventors: Tim Edward Alcacio, Winnie Hoyan Chan, Mark Guzman, Asayuki Kamatani, Cynthia Palmer, Nabil Saeed, Jill Melissa Scott, Jayaram Kasturi Srirangam